SCHEMBL6631441

SCHEMBL6631441

CC1(O)CN(C(=O)C(F)(F)F)CCc2ccc(Cl)cc21

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 5/20 0.49
▸ ESR2 Q92731 5/20 0.49
▸ NOTUM Q6P988 3/20 0.40
▸ PDK2 Q15119 2/20 0.39
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ RIPK1 Q13546 1/20 0.36
▸ AXL P30530 1/20 0.36
▸ TYRO3 Q06418 1/20 0.36
▸ MERTK Q12866 1/20 0.36
▸ CNR1 P21554 2/20 0.36
▸ HTR2A P28223 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ CNR2 P34972 1/20 0.35
▸ ABHD6 Q9BV23 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3824396 0.85 ESR1 (0.46) ESR1ESR2PDK2PKMABHD6
SCHEMBL2585109 0.78 ESR1 (0.62) ESR1ESR2NOTUMHTR2AHTR2C
SCHEMBL25206226 0.76 ESR2 (0.76) ESR1ESR2RIPK1PKMABHD6
SCHEMBL29989790 0.76 ESR1 (0.76) ESR1ESR2RIPK1AXLTYRO3
SCHEMBL2821470 0.76 ESR1 (0.76) ESR1ESR2RIPK1AXLTYRO3
SCHEMBL1095888 0.74 ESR1 (0.58) ESR1ESR2NOTUMPDK2RIPK1
SCHEMBL1095848 0.73 ESR1 (0.56) ESR1ESR2NOTUMPDK2RIPK1
SCHEMBL3282323 0.72 ESR1 (0.49) ESR1ESR2CNR1HTR2AHTR2C
SCHEMBL3282297 0.72 ESR1 (0.49) ESR1ESR2CNR1HTR2AHTR2C
SCHEMBL31121204 0.72 ESR1 (0.49) ESR1ESR2CNR1HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411881-A4 5HT sb 2C /sb RECEPTOR MODULATORS ARENA PHARM INC (US) 2004-07-07 — — EP disclosed
EP-1411881-A2 5HT sb 2C /sb RECEPTOR MODULATORS Arena Pharmaceuticals, Inc. (US) 2004-04-28 — — EP disclosed
WO-2003086306-A2 5HT2C RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. (US) 2003-10-23 — — WO disclosed
Send feedback